NgospelMedia.Net is The No. 1 International Largest Repository of Your Favourite Gospel Entertainment Website, WorldWide, Nigeria. We Published Latest Naija Gospel Music Downloads, Videos; Lyrics, Artiste Biography, Daily Devotionals. NgospelMedia is mainly a Christian Website, as the Domain Name Speaks; Gospel; Which is also tagged as a Gospel On-line Ministry for Souls Winning...

COVID-19 vaccines for all Americans may be ready by March: HHS secretary


- Advertisement -

COVID-19 vaccines for all Americans may be ready by March: HHS secretary 1

Enough coronavirus vaccine doses for every American who wants one could be manufactured as early as March next year, Health and Human Services Secretary Alex Azar said Thursday.

“We project having enough for every American who wants a vaccine by March to April 2021,” he predicted at the virtual Goldman Sachs Healthcare Conference on COVID-19, according to CNBC.

He also expects that up to 100 million doses could be available by the end of this year — enough “to cover especially vulnerable populations.”

The US is manufacturing doses for all six vaccine candidates backed by the feds’ Operation Warp Speed, including those that are in late-stage testing from Moderna, Pfizer, AstraZeneca and Johnson & Johnson, according to Azar.

He added that the US is also obtaining needles, syringes and bottles needed for the shots.

President Trump has predicted that a vaccine could be authorized as early as October and that there’d be enough doses for every American by April. However, new FDA regulations will likely push any authorization past Election Day.

Azar said health officials believe authorizing a vaccine for emergency use was OK in “only specific circumstances” and where there are “sufficient amounts of vaccine already manufactured,” CNBC said.

Azar also said that tens to hundreds of thousands of doses of an antibody treatment made by Regeneron could be ready for this fall, pending authorization from the US Food and Drug Administration.

The still-experimental drug was given to Trump for “compassionate use” but has not yet passed through clinical trials or been approved for widespread use by the FDA.

The company on

Wednesday asked the agency for emergency approval, saying it currently has enough doses for about 50,000 patients and expects to have enough for 300,000 patients in the next few months.

With Post wires

- Advertisement -

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

- Advertisement -

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More